GBM’s resistance and invasiveness are contributed to by aberrant p53 function influenced by overexpressed MDM2 and MDM4 proteins, as well as an increase in CXCR4 expression (Daniele et al., 2021). This evidence concerns the gene MDM2 and glioblastoma.